Evidence map›Paper›PMID 42877910›Full record

ArticleAdvanced functional materials2026

Immune-Responsive Bioinks Enable Vision-Guided

Seol-Ha Jeong, Eleftheria-Angeliki Valsami, Ki-Tae Kim, Kijun Park, Jihyun Kim, Javier Alejandro Lozano Soto, Jaeseo Lee, Rafael Alejandro Cornejo Rodríguez, Danilo Martins Dos Santos, Jarno Hiemstra and 14 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Advanced functional materials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Seol-Ha JeongDivision of Engineering in Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, MA, 02139, USA.
Eleftheria-Angeliki ValsamiJoslin-Beth Israel Deaconess Foot Center and The Rongxiang Xu, MD, Center for Regenerative Therapeutics, Beth Israel Deaconess Medical Center, Harvard Medical School, MA, 02215, USA.
Ki-Tae KimDepartment of Molecular Genetics & Dental Pharmacology, School of Dentistry and Dental Research Institute, Dental Multi-omics Center, Seoul National University, Seoul, 03080, Republic of Korea.
Kijun ParkDivision of Engineering in Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, MA, 02139, USA.
Jihyun KimDivision of Engineering in Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, MA, 02139, USA.
Javier Alejandro Lozano SotoDivision of Engineering in Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, MA, 02139, USA.
Jaeseo LeeDivision of Engineering in Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, MA, 02139, USA.
Rafael Alejandro Cornejo RodríguezDivision of Engineering in Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, MA, 02139, USA.
Danilo Martins Dos SantosDivision of Engineering in Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, MA, 02139, USA.
Jarno HiemstraDivision of Engineering in Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, MA, 02139, USA.
Mei L L Cham-PérezDivision of Engineering in Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, MA, 02139, USA.
Montserrat Legorreta GonzalezDivision of Engineering in Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, MA, 02139, USA.
Soo A KimDivision of Engineering in Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, MA, 02139, USA.
Jungmok SeoSchool of Electrical and Electronic Engineering, Yonsei University, Seoul 03722, Republic of Korea.
Zhuqing LiJoslin-Beth Israel Deaconess Foot Center and The Rongxiang Xu, MD, Center for Regenerative Therapeutics, Beth Israel Deaconess Medical Center, Harvard Medical School, MA, 02215, USA.
Brendan Craig ThibaultDepartment of Electrical and Computer Engineering, University of Massachusetts-Dartmouth, MA, 02747, USA.
Nebras SobahiDepartment of Electrical and Computer Engineering, King Abdulaziz University, Jeddah, 21589, Saudi Arabia.
Mohammad Asif HussainDepartment of Electrical and Computer Engineering, King Abdulaziz University, Jeddah, 21589, Saudi Arabia.
Kyungsang KimDepartment of Radiology, Mass General Brigham and Harvard Medical School, Boston, MA, USA.
Lance FiondellaDepartment of Electrical and Computer Engineering, University of Massachusetts-Dartmouth, MA, 02747, USA.
Aristidis VevesJoslin-Beth Israel Deaconess Foot Center and The Rongxiang Xu, MD, Center for Regenerative Therapeutics, Beth Israel Deaconess Medical Center, Harvard Medical School, MA, 02215, USA.
Woo-Jin KimDepartment of Molecular Genetics & Dental Pharmacology, School of Dentistry and Dental Research Institute, Dental Multi-omics Center, Seoul National University, Seoul, 03080, Republic of Korea.
Georgios TheocharidisJoslin-Beth Israel Deaconess Foot Center and The Rongxiang Xu, MD, Center for Regenerative Therapeutics, Beth Israel Deaconess Medical Center, Harvard Medical School, MA, 02215, USA.
Su Ryon ShinDivision of Engineering in Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, MA, 02139, USA.

Funding

Suturable bioprinted vascularized muscle constructs for treatment of skeletal muscle lossR01AR077132 · NIAMS · BRIGHAM AND WOMEN'S HOSPITAL · PI SHIN, SU RYON, TAMAYOL, ALI · 2021 to 2025
$2.6M
Targeted mRNA Delivery to Improve Diabetic Wound HealingK01DK139434 · NIDDK · BETH ISRAEL DEACONESS MEDICAL CENTER · PI Georgios Theocharidis · 2024 to 2026
$454k
NIAMS NIH HHS R01 AR077132NIDDK NIH HHS K01 DK139434
6 · The paper itself

Abstract

Chronic diabetic wounds remain a major clinical challenge because persistent inflammation, hypoxia, and immune dysregulation prevent the transition of macrophages from pro-inflammatory M1 states to pro-regenerative M2 phenotypes. Here, we report an immunomodulatory colloidal bioink that integrates zein-based oxygen-generating microparticles and human mesenchymal stem cells within a porous, mechanically robust matrix for adaptive

Indexed as

immune-responsive bioinkin situ bioprintingmacrophage polarizationoxygen generating microparticlesrobot printing

Identifiers

PMID42877910
PMCPMC13668246

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.